Gilead Sciences, Inc. portfolio
GILDUnited States
Every trademark Gilead Sciences, Inc. holds, newest filings first. The portfolio has 442 marks filed under 6 owner names.
Search this portfolio
- Trademarks on file
- 442
- Active
- 216
- Owner names grouped
- 6
Portfolio
All trademarks
50 marks per page, newest filing date first. Pick an office to narrow the list.
| Mark | Status | Office | Classes | Filed |
|---|---|---|---|---|
| FOCUS | examining | USPTO | 35, 36 | 2026-04-06 |
| FOCUS | examining | USPTO | 35, 36 | 2026-04-03 |
| GIGI | allowed | USPTO | 42, 44 | 2026-02-03 |
| GILEAD | allowed | USPTO | 44 | 2026-02-02 |
| GILEAD | allowed | USPTO | 36 | 2026-01-26 |
| GILEAD | allowed | USPTO | 42 | 2026-01-26 |
| GILEAD | allowed | USPTO | 35 | 2026-01-23 |
| PROVEN SURVIVAL IN YOUR HANDS | allowed | USPTO | 44 | 2025-10-08 |
| CHOOSE U | registered | UKIPO | 35 | 2025-05-29 |
| CHOOSE YOU | registered | UKIPO | 35 | 2025-05-29 |
| CHOOSE U | registered | USPTO | 35 | 2025-02-05 |
| GILEAD FOR GOOD | abandoned | USPTO | 35 | 2024-12-18 |
| GILEAD FOR GOOD | abandoned | USPTO | 36 | 2024-12-18 |
| SUPPORT PATH | registered | USPTO | 35 | 2024-12-17 |
| GILEAD GO | allowed | USPTO | 44 | 2024-12-11 |
| GILEAD GO | allowed | USPTO | 35 | 2024-12-10 |
| GILEAD GO | allowed | USPTO | 36 | 2024-12-10 |
| GILEAD GO | allowed | USPTO | 42 | 2024-12-10 |
| TALK PREP | registered | USPTO | 44 | 2024-09-23 |
| GILEAD FOUNDATION | allowed | USPTO | 36 | 2024-08-14 |
| YEMI | abandoned | USPTO | 42, 44 | 2024-05-13 |
| GILLIAN | registered | UKIPO | 42, 44 | 2024-02-26 |
| GILLIAN | registered | USPTO | 42, 44 | 2023-10-27 |
| GLOWS INDIGENOUS HEALTH GRANT GUIDING LOCAL OPPORTUNITIES FOR WELLBEING | registered | IP Australia | 36 | 2023-10-24 |
| CANCER STEALS POSSIBILITY. WE'RE TAKING IT BACK. | pending issuance | USPTO | 35, 44 | 2023-08-24 |
| [Design Mark] | registered | USPTO | 9, 16, 35, 36, 39, 41 | 2023-07-31 |
| ZERO HOUR | registered | UKIPO | 9, 44 | 2023-07-10 |
| ZERO HOUR | registered | IP Australia | 9 | 2023-06-28 |
| ZERO HOUR | pending issuance | USPTO | 9 | 2023-03-16 |
| GILEAD OPTICS | mixed | WIPO | 42 | 2023-03-07 |
| CREATING POSSIBLE FUND | registered | UKIPO | 36 | 2023-03-03 |
| HELPING TO BRING MORE LIFE TO PEOPLE WITH CANCER | abandoned | USPTO | 35, 44 | 2023-02-07 |
| ONCOLOGIQ | refused | IP Australia | 41, 44 | 2023-01-13 |
| HCV ACADEMY | registered | IP Australia | 41, 44 | 2022-12-20 |
| GILEAD TOWARD HEALTH EQUITY ONCOLOGY GRANT | registered | USPTO | 36 | 2022-12-13 |
| GILEAD THE TOWARD HEALTH EQUITY ONCOLOGY GRANT | abandoned | USPTO | 36 | 2022-12-13 |
| GILEAD OPTICS | registered | USPTO | 42 | 2022-09-21 |
| CREATING POSSIBLE FUND | registered | USPTO | 36 | 2022-09-14 |
| TOWARD HEALTH EQUITY ONCOLOGY GRANT | registered | USPTO | 36 | 2022-08-17 |
| [Design Mark] | registered | USPTO | 10 | 2022-08-08 |
| GILEAD | registered | USPTO | 10 | 2022-08-04 |
| GILEAD | GLOBAL PATIENT SOLUTIONS | cancelled | WIPO | 41 | 2022-07-27 |
| STOP THE VIRUS | registered | USPTO | 35, 44 | 2022-06-15 |
| HIV FLIX | registered | IP Australia | 41, 44 | 2022-04-08 |
| MBC UNSPOKEN | registered | USPTO | 44 | 2022-03-22 |
| GILEAD | GLOBAL PATIENT SOLUTIONS | abandoned | USPTO | 35, 41, 44 | 2022-02-09 |
| & | registered | USPTO | 35 | 2022-01-28 |
| A DIAGNOSIS IN CONTROL | abandoned | USPTO | 44 | 2021-11-19 |
| ZEROING IN | registered | USPTO | 36 | 2021-09-30 |
| GS-441524 | registered | UKIPO | 5 | 2021-09-29 |
API
Get this data via the API
Everything on this page comes from the Signa API. Pull Gilead Sciences, Inc.'s full portfolio into your own product.
GET/v1/entities/{id}/trademarksEvery trademark in the portfolio, filterable by office and class
GET/v1/entities/{id}/analyticsPortfolio totals, disputes and ownership changes
GET/v1/entities/{id}Company record, ticker, LEI and owner names
GET /v1/entities/{id}/trademarks
ID=ent_019f1c89-67d5-700e-844f-1f78890ad24f
curl https://api.signa.so/v1/entities/$ID/trademarks \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"object": "list",
"data": [
{
"id": "tm_019d707e-3244-767a-a6e4-881920879863",
"mark_text": "FOCUS",
"office_code": "US",
"status": {
"stage": "examining"
},
"filing_date": "2026-04-06"
},
{
"id": "tm_019d6073-895d-73ad-9fc4-1e328b1e8ea3",
"mark_text": "FOCUS",
"office_code": "US",
"status": {
"stage": "examining"
},
"filing_date": "2026-04-03"
}
],
"has_more": true
}